Preparation and evaluation of nicotinic acid sustained-release pellets combined with immediate release simvastatin

International Journal of Pharmaceutics

Volumn 400, Issue 1-2, 2010, Pages 42-48

  Zhao, Xingna ^a   Li, Guofei ^a   Zhang, Lili ^a   Tao, Xiaoguang ^a   Guan, Tingting ^a   Hong, Mo ^a   Tang, Xing ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Content uniformity; Immediate release; Nicotinic acid; Simvastatin; Stability; Sustained release

Indexed keywords

ETHYL CELLULOSE; NICOTINIC ACID; SIMVASTATIN;

ARTICLE; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; PELLET EXTRUSION; PRIORITY JOURNAL; SPHERONIZATION;

CELLULOSE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DRUG COMBINATIONS; DRUG COMPOUNDING; DRUG STABILITY; DRUG STORAGE; EXCIPIENTS; HYPOLIPIDEMIC AGENTS; METHACRYLATES; MICROSCOPY, ELECTRON, SCANNING; NIACIN; POLYMERS; POVIDONE; SIMVASTATIN; SOLUBILITY;

EID: 77957659716     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.08.028     Document Type: Article

References (27)

1. Abbott Laboratories Niaspan tablets: niacin extended-release tablets 2007, Available at:. http://www.rxabbott.com/pdf/niaspan.pdf.
2. Abbott Laboratories, 2008. Simvastatin niacin extended-release tablet. Film Coated, 33. DN1744V1-Simcor-ADRChange-clean-041508.
3. Ansell B.J. Rationale for combination therapy with statin drugs in the treatment of dyslipidemia. Curr. Atheroscler. Rep. 2005, 7:29-33.
4. Ballantyne C.M., Davidson M.H., McKenney J., Keller L.H., Bajorunas D.R., Karas R.H. Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80mg monotherapy: the SEACOST II (high-dose) study. J. Clin. Lipidol. 2008, 2:79-90.
5. Banker G.S. Film coating theory and practice. J. Pharm. Sci. 1966, 55:81-89.
6. Wang, B.-H., Wang, Z.-H., Wang, G., Xu, Q., 2010. Preparation and abnormal infrared behavior of highly-dispersed magnesium oxide powders. Henan Chemical Industry. 03, 01-0037.
7. Birjmohun R.S., Hutten B.A., Kastelein J.J., Stroes E.S. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. J. Am. Coll. Cardiol. 2005, 45:185-197.
8. Bruce L., Diane, Koleng, John J., McGinity, James W. The influence of polymeric subcoats and pellet formulation on the release of chlorpheniramine maleate from enteric coated pellets. Drug Dev. Ind. Pharm. 2003, 29:909-924.
9. Chakrabarti S., Ganguli D., Chaudhuri S., Pal A.K. Crystalline magnesium oxide films on soda lime glass by sol-gel processing. Mater. Lett. 2002, 54:120-123.
10. Desai J., Alexander K., Riga A. Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release. Int. J. Pharm. 2006, 1-2:115-123.
11. Frenning G., Tunón Å., Alderborn G. Modelling of drug release from coated granular pellets. J. Control. Release 2003, 92:113-123.
12. Guo H.X., Heinämäki J., Yliruusi J. Amylopectin as a subcoating material improves the acidic resistance of enteric-coated pellets containing a freely soluble drug. Int. J. Pharm. 2002, 235:79-86.
13. Knop K. Influence of buffer solution composition on drug release from pellets coated with neutral and quaternary acrylic polymers and on swelling of free polymer films. Eur. J. Pharm. Sci. 1996, 4:293-300.
14. Lecomte F., Siepmann J., Walther M., MacRae R.J., Bodmeier R. Polymer blends used for the coating of multiparticulates: comparison of aqueous and organic coating techniques. Pharm. Res. 2004, 21:882-890.
15. McKenney J. New perspectives on the use of niacin in the treatment of lipid disorders. Arch. Intern. Med. 2004, 164:697-705.
16. Meyers C.D., Kamanna V.S., Kashyap ML: niacin therapy in atherosclerosis. Curr. Opin. Lipidol. 2004, 15:659-665.
17. Muschert Sa., Siepmann Fa., Leclercq Bb., Carlin Bc., Siepmann Ja Prediction of drug release from ethylcellulose coated pellets. J. Control. Release 2009, 135:71-79.
18. Ng W.F., Wong M.H., Cheng F.T. Stearic acid coating on magnesium for enhancing corrosion resistance in Hanks' solution. Surf. Coat. Technol. 2010, 11:1823-1830.
19. Ozturk A.G., Ozturk S.S., Palsson B.O., Wheatley T.A., Dressman J.B. Mechanism of release from pellets coated with an ethylcellulose-based film. J. Control. Release 1990, 14:203-213.
20. PhD. Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study). Am. J. Cardiol. 2004, 93:307-312.
21. Shen H.-F., Ren Q. Applications of polyvinylpyrrolidone in pharmaceutics. Chin. J. Pharm. 1996, 12:26.
22. Siepmann F., Muschert S., Leclercq B., Carlin B., Siepmann J. How to improve the storage stability of aqueous polymeric film coatings. J. Control. Release 2008, 126:26-33.
23. Ward S., Lloyd J.M., Pandor A., Holmes M., Ara R., Ryan A., Yeo W., Payne N. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol. Assess. 2007, 11:1-178.
24. Wu C., McGinity J.W. Influence of relative humidity on the mechanical and drug release properties of theophylline pellets coated with an acrylic polymer containing methylparaben as a non-traditional plasticizer. Eur. J. Pharm. Biopharm. 2000, 50:277-284.
25. Li Y., Zhao L.-G., Jing B.-Y., Wang L., Sun J., He Z.-G. Effect of different excipients on the stability of simvastatin tablets. Chin. J. Pharm. 2009, 03. 0101-07.
26. ® NE30D blended with Eudragit L30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets. Drug Dev. Ind. Pharm. 2003, 595-605.
27. ® NE30D blended with Eudragit L30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets. Drug Dev. Ind. Pharm. 2003, 29:357-366.